SEARCH-AGAINST-ASSUMPTION-488:
  Date searched: 2026-07-21
  Original item: ASSUMPTION-488
  Original statement: The morning status asserted OpenStory alive and the metabolism snapshot regenerated on schedule, on a day the metabolism run exited 1 with the db 14.6 days stale. Second consecutive occurrence; occurred on the day PREMISE-109 was validated.

  PROVENANCE:
    Origin: 14a
    Chain: [14a → 15b]
    Original item: ASSUMPTION-488
    Item type: ASSUMPTION (stated)
    Transform at each step:
      14a: Extracted from the 2026-07-20 morning project status transcript, cross-checked against two same-day failure transcripts
      15b: Searched for challenging literature (recurrence after diagnosis, normalization of deviance, finding-to-change latency)
    Current status: NO-CHALLENGE-FOUND

  Challenging evidence found: No — one framing caution only
  Search scope: Moderate. Searched the recurrence-after-diagnosis and organisational-learning literature specifically for evidence that recurrence following a recorded diagnosis is normal, expected, or non-diagnostic. Everything retrieved treats it as a serious signal.

  Sources:
    1. Vaughan's normalization of deviance, as documented in the qualitative systematic review of its application in high-risk industries (ScienceDirect S0022437522001827) and in the Challenger literature (retrieved 2026-07-21). Deviance from correct practice becomes normalised when a small departure repeatedly fails to cause harm; recurrence without response is the mechanism by which the deviation becomes the new baseline. Supports the item.
    2. Institute of Medicine, "To Err Is Human: Building a Safer Health System" (1999), chapter on why errors happen (NBK225171, retrieved 2026-07-21). Organisations routinely fail to expose and correct latent errors even when the cost of doing so is small, missing cheap opportunities for improvement before a serious failure. This is the item's situation described generically; it supports rather than challenges.
    3. Same source, on response: punitive responses to active errors are not effective at preventing recurrence, and known defects recur when the underlying latent conditions are left unaddressed. A caution about the remedy space, not the observation.
    4. Retrieved CAPA literature (Deltek, "The CAPA Process"; The FDA Group, "Definitive Guide to CAPA"; retrieved 2026-07-21). CAPA programmes most often fail at follow-up rather than investigation: the effectiveness check is dropped, the failure recurs, and the audit record documents the whole cycle. Directly describes the pattern the item reports and treats it as a known, named failure of the correction process.

  Strength of challenge: None (to the claim); Weak (to the inference from n=2)
  Summary: This was searched disconfirmatorily and no contradicting evidence was found. Every retrieved source treats recurrence of a named defect after its diagnosis has been recorded as a serious signal rather than noise, and the CAPA literature describes the exact cycle — investigation completed, effectiveness check omitted, failure recurs, record documents both — as the most common way correction programmes fail. The item's observation stands. The only caution worth registering is about strength of inference rather than fact: a second consecutive occurrence is n=2, and the item's framing ("second consecutive") carries more weight than two observations can bear on their own. It establishes that the first occurrence was not a one-off; it does not yet establish a rate, and the distance between "recurred twice" and "the diagnosis never propagates" is the distance between this item and PRESUMPTION-506, which makes the general claim and should carry the general burden. The item's own note acknowledges this by scoping itself to the recurrence question.
  Specific risks: Under-reaction risk dominates. If the recurrence is treated as noise, the normalization-of-deviance path is exactly the one the literature describes — each non-harmful recurrence lowers the threshold for the next. The smaller symmetric risk is over-reading: building a general propagation-failure theory on two data points, when the same two points are consistent with a single unfixed root cause in one agent.
  Mitigations available: Convert the observation into a rate rather than a count — enumerate the morning run's read set (the item's own measurement 1 of 5) and then count occurrences over 30 days, which distinguishes "twice" from "every day it could have." Adopt the CAPA effectiveness-check discipline explicitly: define, at diagnosis time, what evidence would show the fix worked and by when, and do not close the finding until that evidence exists. Avoid the punitive framing the safety literature warns is ineffective; the defect is that no step consumes the diagnosis, not that an agent misbehaved.
  Recommendation: NO-CHALLENGE-FOUND

  STEELMAN:
    Item: ASSUMPTION-488
    Strongest counterargument: There is no serious case against the observation, and the only available challenge is to how much weight two occurrences can carry. "Second consecutive occurrence" is rhetorically strong and evidentially thin: it rules out a one-off and nothing more. Two events are equally consistent with a general architectural failure to propagate findings — the PRESUMPTION-506 reading — and with a single unremediated root cause inside one agent's morning routine, which is a much smaller and much cheaper problem. The distinction matters because the two diagnoses call for entirely different responses, and the more dramatic one is currently supported by the same two data points as the mundane one. The CAPA literature also suggests a reframing that is more useful than either: this is a textbook effectiveness-check omission, in which the investigation is completed and correctly recorded, no criterion is defined for what would show the fix worked, and the failure recurs while the record documents the full cycle. That is a named, common, well-studied process defect with a known remedy, and treating it as such is more actionable than treating it as evidence of a deep architectural absence.
    What would need to be true for C2A2 to be safe: That the recurrence is measured as a rate over a defined window rather than reported as a count, and that the finding is not closed until an effectiveness criterion defined at diagnosis time has been met.
    How to test: Enumerate the morning run's read set and then count, over the last 30 days, the number of days on which the morning status asserted OpenStory alive against the number of days the metabolism run exited non-zero. A rate near 1.0 is architectural; a rate near 2/30 is a specific unfixed bug.
